New expectations and new perspectives generated from cell therapy to predictive diagnosis technologies are appearing for the treatment and the prevention of many human diseases, and a growing number of Biopharma and culture media manufacturers are using ProCel® yeast nutrients in their production. Recombinant proteins, antibodies, vitamins, antibiotics and vaccine productions, as well as ready-to-use-media and culture media for diagnostic purposes can all benefit from use of the ProCel® product range.

In Biopharma, ProCel® consistent nutrients support drug development activities from R&D to commercial production by offering Procelys expertise through a range of products that are intended to meet the specific needs of the microorganisms, mammalian cells, and insect cells involved in drug manufacturing. In Diagnostic culture media, ProCel® nutrients supports the rapid detection and the growth improvement of many pathogenic microorganisms.
ProCel® nutrients also provide the amino acids, peptides, vitamins and minerals needed for expression system performance, together with the solubility, filterability, and lot-to-lot consistency needed to meet the quality standards required by the Biopharma and culture media industries.